Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1760)	9/28/2007 12:07:45 PM
From: Jibacoa	Read Replies (1) of 3722

CRA Traded earlier above its Sep 19 H of 14.22 It needs to close above its Aug 17 H of 14.50. (The intraday H so far is 14.38) bigcharts.marketwatch.com It announced today that it received a milestone payment of $2M from MRK, under the cathepsin K inhibitor collaboration agreement. MK-0822 is an orally,selective inhibitor of cathepsin K enzyme, which is in a PIII for osteoporosis. The cathepsin K enzyme is believed to play a role in the osteoclastic process & its inhibition is a different approach to treat osteoporosis than the currently approved treatments, such as bisphosphonates. CRA Is expected to trim its losses to $0.07/shr in 2008 vs. the $0.25/shr in 2007 & for 2009 it is expected to be on the black.It has plenty of room to run. (The Feb 200 H was 276 <g>) bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next